See more : Vaycaychella Inc. (VAYK) Income Statement Analysis – Financial Results
Complete financial analysis of Megasoft Limited (MEGASOFT.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Megasoft Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Yuanda China Holdings Limited (2789.HK) Income Statement Analysis – Financial Results
- Daiwa Co.,Ltd. (8247.T) Income Statement Analysis – Financial Results
- Krynicki Recykling Spólka Akcyjna (KRC.WA) Income Statement Analysis – Financial Results
- Vitreous Glass Inc. (VCI.V) Income Statement Analysis – Financial Results
- Brand 24 S.A. (B24.WA) Income Statement Analysis – Financial Results
Megasoft Limited (MEGASOFT.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.megasoft.com
About Megasoft Limited
Megasoft Limited engages in the research and development, production, distribution, and sale of chemicals and pharmaceutical products. It intends to pursue in defense and manufacturing areas. The company was founded in 1994 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 373.95M | 19.71M | 523.96M | 594.02M | 567.33M | 618.74M | 662.59M | 701.42M | 656.83M | 766.79M | 1.06B | 1.15B | 1.50B | 1.68B | 3.03B | 3.26B |
| Cost of Revenue | 31.88M | 38.64M | 321.43M | 320.33M | 289.12M | 379.77M | 420.42M | 374.86M | 241.69M | 37.14M | 85.72M | 13.76M | 578.09M | 136.03M | 84.33M | 243.58M |
| Gross Profit | 342.07M | -18.93M | 202.53M | 273.70M | 278.20M | 238.96M | 242.18M | 326.56M | 415.14M | 729.65M | 969.35M | 1.14B | 925.57M | 1.54B | 2.95B | 3.02B |
| Gross Profit Ratio | 91.47% | -96.04% | 38.65% | 46.08% | 49.04% | 38.62% | 36.55% | 46.56% | 63.20% | 95.16% | 91.88% | 98.81% | 61.55% | 91.90% | 97.22% | 92.53% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 86.80M | 54.34M | 18.16M | 15.16M | 17.82M | 24.36M | 43.53M | 45.77M | 421.58M | 136.73M | 0.00 | 216.98M | 259.96M | 91.60M | 79.93M |
| Selling & Marketing | 0.00 | 1.70M | 77.36M | 79.90M | 58.62M | 21.02M | 9.71M | 19.90M | 17.86M | 12.78M | 33.46M | 0.00 | 57.35M | 84.18M | 0.00 | 0.00 |
| SG&A | 20.56M | 88.51M | 131.70M | 98.06M | 73.78M | 38.84M | 34.07M | 63.43M | 63.63M | 434.36M | 446.36M | 0.00 | 274.33M | 344.14M | 91.60M | 79.93M |
| Other Expenses | -3.80M | 376.30M | 265.82M | 66.89M | 55.03M | 81.56M | 7.70M | 6.69M | -914.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 49.53M | 165.13M | 273.48M | 255.93M | 234.26M | 186.78M | 189.21M | 321.59M | 326.52M | 647.40M | 862.71M | 1.05B | 718.78M | 1.14B | 2.91B | 2.81B |
| Cost & Expenses | 49.53M | 203.77M | 594.91M | 576.25M | 523.38M | 566.55M | 609.63M | 696.45M | 568.21M | 684.54M | 948.43M | 1.06B | 1.30B | 1.27B | 2.99B | 3.06B |
| Interest Income | 0.00 | 41.83M | 1.20M | 1.75M | 1.37M | 1.23M | 1.36M | 1.43M | 483.00K | 81.81M | 2.23M | 870.00K | 213.00K | -12.41M | -12.41M | 6.83M |
| Interest Expense | 170.63M | 100.63M | 21.33M | 46.03M | 57.89M | 51.33M | 46.89M | 46.24M | 52.36M | 0.00 | 93.05M | 95.30M | 71.38M | 133.65M | 214.86M | 219.40M |
| Depreciation & Amortization | 31.88M | 28.41M | 36.14M | 36.30M | 43.76M | 37.58M | 43.12M | 51.18M | 67.03M | 108.38M | 118.70M | 123.33M | 129.02M | 143.43M | 242.72M | 260.41M |
| EBITDA | 284.73M | 251.10M | 118.01M | 109.66M | 118.73M | 106.11M | 105.99M | 132.58M | 163.47M | 206.54M | 259.82M | 234.94M | 381.44M | 491.41M | 282.28M | 842.37M |
| EBITDA Ratio | 76.14% | 1,288.39% | 42.10% | 18.65% | 25.09% | 26.82% | 15.23% | 6.56% | 20.93% | 25.24% | 22.83% | 18.62% | 22.33% | 33.00% | 9.50% | 14.10% |
| Operating Income | -121.10M | -205.22M | -201.08M | 7.79M | 9.95M | -17.86M | 52.97M | 4.97M | 88.62M | 85.13M | 29.17M | 16.32M | 181.04M | 399.56M | 34.14M | 210.88M |
| Operating Income Ratio | -32.38% | -1,041.21% | -38.38% | 1.31% | 1.75% | -2.89% | 7.99% | 0.71% | 13.49% | 11.10% | 2.76% | 1.41% | 12.04% | 23.80% | 1.13% | 6.47% |
| Total Other Income/Expenses | 203.32M | 318.95M | 253.50M | 10.67M | -37.25M | -45.13M | -42.08M | 17.06M | -70.88M | -84.68M | -77.45M | -75.19M | 0.00 | -185.23M | -283.79M | 151.68M |
| Income Before Tax | 82.22M | 113.73M | 52.42M | 18.46M | 6.69M | 7.05M | 10.89M | 22.03M | 17.74M | 445.00K | 29.17M | 16.32M | 181.04M | 214.33M | -249.65M | 367.59M |
| Income Before Tax Ratio | 21.99% | 577.01% | 10.00% | 3.11% | 1.18% | 1.14% | 1.64% | 3.14% | 2.70% | 0.06% | 2.76% | 1.41% | 12.04% | 12.76% | -8.24% | 11.27% |
| Income Tax Expense | 6.36M | 414.37M | 6.21M | -26.00K | -378.00K | 3.71M | -6.02M | -5.16M | 4.76M | 5.84M | 2.39M | 4.65M | 6.12M | -2.73M | -28.66M | 41.93M |
| Net Income | -127.47M | 88.29M | 46.21M | 18.48M | 7.07M | 3.34M | 16.91M | 27.19M | 12.98M | 6.28M | 26.78M | 11.67M | 174.92M | 217.06M | -220.99M | 325.66M |
| Net Income Ratio | -34.09% | 447.96% | 8.82% | 3.11% | 1.25% | 0.54% | 2.55% | 3.88% | 1.98% | 0.82% | 2.54% | 1.01% | 11.63% | 12.93% | -7.29% | 9.98% |
| EPS | -1.73 | 1.20 | 0.74 | 0.35 | 0.13 | 0.06 | 0.32 | 0.52 | 0.25 | 0.14 | 0.51 | 0.22 | 3.33 | 4.13 | -4.21 | 6.20 |
| EPS Diluted | -1.73 | 1.20 | 0.74 | 0.35 | 0.13 | 0.06 | 0.32 | 0.52 | 0.25 | 0.14 | 0.48 | 0.21 | 3.26 | 4.13 | -4.12 | 6.18 |
| Weighted Avg Shares Out | 73.68M | 73.77M | 62.86M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M | 43.98M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M |
| Weighted Avg Shares Out (Dil) | 73.68M | 73.77M | 62.86M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M | 52.53M | 44.47M | 55.29M | 54.37M | 53.59M | 52.53M | 53.60M | 53.06M |
No news found for: MEGASOFT.BO
Source: https://incomestatements.info
Category: Stock Reports